DavidWRussellMD
Hematology • Seattle, WAProfessor, Medicine, University of Washington School of Medicine
Are you Dr. Russell?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 22 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1951 E 120th St
Apt 2
Seattle, WA 44106Phone+1 206-731-3241
Summary
- Dr. David Russell, MD is a hematologist in Seattle, Washington. He is currently licensed to practice medicine in Washington. He is affiliated with UW Medicine/University of Washington Medical Center and Seattle Children's Hospital.
Education & Training
Weill Cornell MedicineClass of 1989
Certifications & Licensure
WA State Medical License 1992 - 2021
Publications & Presentations
PubMed
- Does race make a difference in how long men with advanced prostate cancer live when treated with abiraterone or enzalutamide?Daniel J George, Krishnan Ramaswamy, Ahong Huang, David Russell, Neil M Schultz
Future Oncology. 2022-10-13 - 29 citationsEnzalutamide Monotherapy vs Active Surveillance in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial.Neal D Shore, Joseph Renzulli, Neil E Fleshner, Courtney M P Hollowell, Srinivas Vourganti
JAMA Oncology. 2022-08-01 - 17 citationsStatin and metformin use and outcomes in patients with castration-resistant prostate cancer treated with enzalutamide: A meta-analysis of AFFIRM, PREVAIL and PROSPER.Anthony M Joshua, Andrew Armstrong, Megan Crumbaker, Howard I Scher, Johann de Bono
European Journal of Cancer. 2022-07-01
Press Mentions
Ambys Medicines Announces Formation of Clinical and Scientific Advisory Boards with Leading Liver Disease and Cell and Gene Therapy ExpertsJune 27th, 2022
